OptimizeRx Corp
OPRX18.920USD
+1.140+6.41%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
351.08MMarket Cap
LossP/E TTM
More Details of OptimizeRx Corp Company
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Company Info
Ticker SymbolOPRX
Company nameOptimizeRx Corp
IPO dateMay 18, 2005
CEOMr. Stephen L. (Steve) Silvestro
Number of employees106
Security typeOrdinary Share
Fiscal year-endMay 18
Address260 Charles Street
CityWALTHAM
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code02453
Phone12486516558
Websitehttps://www.optimizerx.com/
Ticker SymbolOPRX
IPO dateMay 18, 2005
CEOMr. Stephen L. (Steve) Silvestro
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
134.73K
+13.12%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
78.55K
+24.83%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
67.23K
+30.28%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
62.27K
+33.50%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
30.93K
-26.45%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Mr. Brendan Merrell
Mr. Brendan Merrell
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Marion K. Odence-Ford
Ms. Marion K. Odence-Ford
General Legal Officer and Chief Human Resources Officer
General Legal Officer and Chief Human Resources Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
134.73K
+13.12%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
78.55K
+24.83%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
67.23K
+30.28%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
62.27K
+33.50%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 23
Updated: Sat, Aug 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Whetstone Capital Advisors, LLC
8.12%
Weintraub (Michael)
7.46%
BlackRock Institutional Trust Company, N.A.
5.89%
The Vanguard Group, Inc.
4.96%
Royce Investment Partners
4.26%
Other
69.31%
Shareholders
Shareholders
Proportion
Whetstone Capital Advisors, LLC
8.12%
Weintraub (Michael)
7.46%
BlackRock Institutional Trust Company, N.A.
5.89%
The Vanguard Group, Inc.
4.96%
Royce Investment Partners
4.26%
Other
69.31%
Shareholder Types
Shareholders
Proportion
Investment Advisor
29.61%
Investment Advisor/Hedge Fund
21.31%
Individual Investor
15.94%
Hedge Fund
14.33%
Research Firm
5.26%
Pension Fund
0.51%
Venture Capital
0.14%
Bank and Trust
0.11%
Insurance Company
0.04%
Other
12.75%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
261
14.95M
80.84%
-7.34M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
2023Q1
407
14.85M
86.69%
-4.67M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Whetstone Capital Advisors, LLC
1.51M
8.16%
--
--
Apr 18, 2025
Weintraub (Michael)
1.38M
7.49%
--
--
Apr 29, 2025
BlackRock Institutional Trust Company, N.A.
1.17M
6.31%
+5.50K
+0.47%
Mar 31, 2025
The Vanguard Group, Inc.
921.85K
4.98%
-13.71K
-1.47%
Mar 31, 2025
Royce Investment Partners
994.30K
5.38%
-75.26K
-7.04%
Mar 31, 2025
William Blair & Company, L.L.C. (Research)
631.03K
3.41%
+29.65K
+4.93%
Mar 31, 2025
Rice Hall James & Associates, LLC
576.17K
3.12%
-1.57K
-0.27%
Mar 31, 2025
Febbo (William J)
530.85K
2.87%
-83.11K
-13.54%
Apr 29, 2025
Parkman Healthcare Partners LLC
475.00K
2.57%
+475.00K
--
Mar 31, 2025
Kennedy Capital Management LLC
478.40K
2.59%
-115.60K
-19.46%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
